Does parenteral oestrogen therapy flare up disease activity in patients with systemic lupus erythematosus complicated by haemorrhagic cystitis?
Yang
L Y
LY
Huang
W J
WJ
Chen
W P
WP
Fu
L W
LW
Lin
C Y
CY
D000293:Adolescent; D003520:Cyclophosphamide / Q000009:adverse effects; D003556:Cystitis / Q000150:complications / Q000188:drug therapy*; D004967:Estrogens / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006470:Hemorrhage / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy*
D004967:Estrogens; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide